Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Update: IHR Emergency Committee, CDC Recommendations

WHO: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – Statement by WHO Director-General, Dr Margaret Chan
9 July 2013
“Cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) have been reported regularly to WHO since 2012. In order to take an independent expert view of the situation and to be prepared for any further action, should it be required, the Director-General convened a meeting of the International Health Regulations Emergency Committee. The Emergency Committee is composed of international experts from a variety of relevant disciplines and all Regions of WHO, their task is to provide expert technical advice to the Director-General in accordance with the IHR (2005) [see link to list of members below].

“The first meeting of the Committee was held on Tuesday, 9 July 2013, from 12:00 to 15:00 Geneva time (CET).

“After reviewing data on the current situation provided by the Secretariat, and information presented to the Committee by officials of several States Parties which have, or have had, cases of MERS-CoV, and after further deliberation, the Committee considered that additional information was needed in a number of areas.

“The Committee also considered it needed time for further discussion and consideration. In this regard, it noted that a second Committee meeting is set to be held Wednesday, 17 July 2013, at 12:00 Geneva time (CET).
http://www.who.int/ihr/procedures/statements_20130709/en/index.html

List of Members of the International Health Regulations (2005) Emergency Committee concerning Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
http://www.who.int/ihr/procedures/emerg_comm_members_2013/en/index.html

.

WHO: Global Alert and Response (GAR) – Disease Outbreak News
http://www.who.int/csr/don/2013_03_12/en/index.html
Middle East respiratory syndrome coronavirus (MERS-CoV) – update 11 July 2013  Excerpt
The Ministry of Health (MoH) in Saudi Arabia has announced an additional laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the country.

The patient is a 66 year-old man from Asir region with an underlying health condition. He is currently in critical but stable condition.

In addition, a Qatari patient earlier confirmed with MERS-CoV infection, who was being treated in the United Kingdom died on 28 June 2013.

Globally, from September 2012 to date, WHO has been informed of a total of 81 laboratory-confirmed cases of infection with MERS-CoV, including 45 deaths.

Based on the current situation and available information, WHO encourages all Member States to continue their surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns…

.

CDC/MMWR Watch – July 12, 2013 / Vol. 62 / No. 27
http://www.cdc.gov/mmwr/mmwr_wk.html
Update: Recommendations for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Weekly
July 12, 2013 / 62(27);557-557
On June 11, 2013, CDC issued interim infection prevention and control recommendations for hospitalized patients with known or suspected Middle East respiratory syndrome coronavirus (MERS-CoV) infection in U.S. hospitals (1). To date, no MERS-CoV cases have been reported in the United States; however, cases have been reported in eight other countries (2). Recent published reports (3,4) have described limited health-care transmission of MERS-CoV, including cases among health-care personnel in international settings. These published reports highlight the need for rapid detection of infectious patients and adherence to correct infection prevention measures to prevent transmission of the virus among patients, health-care personnel, and visitors.

In coming months, the U.S. health-care system might be called upon to provide care to patients infected with MERS-CoV. Front-line providers and health-care organizations should be prepared to care for MERS-CoV patients as part of routine operations. To aid providers and facilities, CDC has developed checklists that identify key actions that can be taken now to enhance preparedness for treating persons with MERS-CoV infection and compiled a list of preparedness resources (available at http://www.cdc.gov/coronavirus/mers/preparedness).

Additional information, including guidance on case definitions, infection control, case investigation, and specimen collection and testing, is available at the CDC MERS website (2).         The MERS website contains the most current information and guidance, which is subject to change. State and local health departments with questions should contact the CDC Emergency Operations Center at telephone, 770-488-7100.

References

    1. CDC. Interim infection prevention and control recommendations for hospitalized patients with Middle East respiratory syndrome coronavirus (MERS-CoV). Atlanta, GA: US Department of Health and Human Services, CDC; 2013. Available at http://wwwdev.cdc.gov/coronavirus/mers/infection-prevention-control.html.
    2. CDC. Middle East respiratory syndrome (MERS). Atlanta, GA: US Department of Health and Human Services, CDC; 2013. Available at http://www.cdc.gov/coronavirus/mers/index.html.
    3. Assiri A, McGeer A, Perl TM, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 2013. Epub June 19, 2013.
    4. Mailles A, Blanckaert K, Chaud P, et al. First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro Surveill 2013;18(24).

http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6227a4.htm?s_cid=mm6227a4_w